Tricuspid valve replacement: a five-year appraisal.
Organic disease of the tricuspid valve required surgery in 18% of all patients undergoing valve replacement over a five-year period. Differentiation of organic from functional disease is difficult and may be made only at open-heart surgery. The results of a series of 56 patients who underwent tricuspid valve replacement are presented; of these, 53 had organic disease. Operative mortality at the end of five years had fallen to 7% with significant clinical improvement in 79% of patients, a reduction in cardiothoracic ratio in 81%, and a low incidence of postoperative tricuspid incompetence.
D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000401:mortality*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D014261:Tricuspid Valve / Q000601:surgery*